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Since 1998, after we started the support group for neonatal 
hearing screening, many other hearing screening programs 
were held in Brazil. In Alagoas, the first program started 
in 2003, but none of its results were published. Hearing is 
paramount for human communication; therefore, childhood 
hearing loss can impair speech acquisition, emotional, 
educational and social development. Aim: to present the 
results achieved in a neonatal hearing screening program in 
Maceió. Materials and Methods: a retrospective analytical study 
was carried out in order to study the results from tests carried 
out from September 2003 to December 2006 in a private 
hospital of Maceió. Results: from a total of 2002 newborns, 
1,626 fitted the inclusion criteria, 835 (51.4%) males. The 
hearing screening was considered appropriate in 1416 cases 
(87.1%), and the most frequently found age was between 
16 and 30 days. Finally, 163 (10.0%) children presented risk 
indicators for hearing loss, and hyperbilirubinemia was the 
most common indicator. Conclusions: statistical results 
obtained from this hearing screening program show the 
importance of holding such programs. This study is important 
because it contributes to further regional or multinational 
studies.
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INTRODUCTION
Communication skills is a distinctive trace of human 
existence, being one of the major factors associated with 
an individual’s well being. Within this context, hearing 
plays a fundamental role, since it is considered a cor-
nerstone on top of which we build the complex human 
communication system1. Thus, auditory sensorial privation 
in children impairs not only their communication, but also 
their receptive and expressive language potential, their 
learning (reading and writing), their school performance 
and their social and emotional development2.
The first two years of a child’s life have been 
considered a critical period for the apprehension and 
development of hearing and language skills. One of the 
main reasons for that is the fact that the central nervous 
system has a great plasticity when stimulated earlier on, 
especially before 6 months of age, increasing the number 
of nervous connections and, consequently, improving 
auditory pathway rehabilitation3.
The Brazilian Committee on Hearing Loss During 
Childhood - Comitê Brasileiro sobre Perdas Auditivas na 
Infância (CBPAI)4 recommends the implementation of 
Universal Neonatal Hearing Screening (UNHS) - Triagem 
Auditiva Neonatal Universal (TANU). The test must be 
carried out in all children, from birth until before 4 months 
of age, and if there is confirmed hearing deficiency, they 
must be treated before 7 months of age. The main goal 
of hearing screening is to identify probable cases of hea-
ring disorders that can have medical and/or educational 
importance5.
The implementation of the hearing screening pro-
gram is viable because of its low cost and the ease of 
execution under training and supervision6. The results 
obtained with these programs are very relevant, such 
as, for example, the program of early identification and 
prevention of hearing disorders of a University in São 
Paulo. In the present investigation, the population was 
broken down in two groups: of high and low auditory 
risk. In the high risk population, during the first year of 
life it was possible to identify about 2.5% of cases of mild 
to profound sensorineural hearing loss. The mean age of 
audiologic diagnosis was 6.6 months of life and 9.8 mon-
ths for intervention (hearing aid and therapy). In the low 
risk population, it was possible to identify sensorineural 
hearing loss in 0.85% of the population5.
The test for objective evaluation of the pre-neural 
peripheral hearing system, with major clinical application 
is the Otoacoustic Emissions Test (OAE). These are a type 
of acoustic energy, described by KEMP7, generated by 
the contractility of the outer hair cells during the active 
mechanism of cochlear function which propagate to the 
middle ear and external auditory canal where they can 
be captured8.
OAEs are the best screening procedure to detect 
hearing impairment early on, because it is a fast, non-
invasive, easy to interpret and it is a high specificity and 
sensitivity test which reflects cochlear response without 
depending on central nervous system maturity9. The most 
clinically used otoacoustic emissions are those by transient 
stimulus and distortion product, the transient are the most 
recommended for Neonatal Auditory Screening (NAS) 
because they are of easy execution and they are able to 
detect hearing loss above 35dBNA10,11. Such technique re-
presents an important progress in the study of hearing loss 
in normal newborns and in those under risk for hearing 
impairment2,7,8,10,12-15.
With the growing increase in the number of Uni-
versal Neonatal Hearing Screening Programs (UNHSP), 
there was a major concern in establishing principles and 
references to control the programs’ efficiency. Principle 
1 stresses that every newborn must have access to hea-
ring screening by physiological measure. Principles 2, 3 
and 4 approach, diagnosis (before four months of age), 
intervention (before seven months of age), and auditory 
monitoring, respectively. Principle number 5 deals on the 
rights of children and families, guaranteed through infor-
med choice, decision and consent. Principle # 6 makes sure 
the children’s family’s and test result information be kept 
confidential. The 7th principle establishes that information 
systems must be used in order to measure and report the 
impacts of neonatal hearing screening programs. And fi-
nally, principle 8 says that the neonatal hearing programs 
must provide data to monitor the quality, establish effective 
cost, mobilize and maintain support in the community, 
according to the legislation and regulations16.
Since 1998, after creating the neonatal hearing scre-
ening support group, many hearing screening programs 
were implemented in our country11. In Alagoas, the first 
program was created in 2003; however publications on 
this topic are yet to be recorded in the state. Thus, the 
present paper aims at presenting the results obtained 
from a neonatal hearing screening program in the city of 
Maceió-AL, since so far we do not have statistical data that 
describes such results.
MATERIALS AND METHODS
We carried out a retrospective, analytical and ob-
servational, cross-sectional study in which we analyzed 
the results of the tests carried out from September of 2003 
through December of 2006, present in a data base from a 
private hospital in the city of Maceió-AL. This study was 
approved by the ethics committee of our institution under 
protocol number 666.
In the sample we included the tests from newborns 
below 3 months of age and took off those non analyzable 
tests and/or out of the criteria pass/failure used by the 
Universal Neonatal Hearing Screening Support Group - 
60
Brazilian Journal of otorhinolaryngology 75 (1) January/feBruary 2009
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
Grupo de Apoio a Triagem Auditiva Neonatal Universal 
(GATANU)11, which will be detailed later on. Data was 
collected by analyzing the tests stored in the hospital’s 
computer. Besides analyzing the results obtained from the 
Transient Stimulus Otoacoustic Emissions (TSOAE), we 
analyzed the correlations of these tests with age, gender, 
and Risk Indicators for Hearing Impairment (RIHI) which 
were reported and recorded.
Hearing impairment risk indicators identified in our 
study were: family history of congenital hearing impair-
ment; congenital infection (syphilis, toxoplasmosis, rubella, 
cytomegalovirus, herpes and AIDS); consanguinity, skull-
facial anomalies - including morphological alterations in 
the ear pinna and external auditory meatus; birth weight 
below 1,500 g or small for the gestational age (SGA); 
hyperbilirubinemia; ototoxic medication - including but 
not limited to aminoglycosides with or without diuretic 
agents; bacterial meningitis; Apgar score of 0-4 in the 1st 
minute or 0-6 in the 5th minute; mechanical ventilation for 
more than 5 days; syndromes associated with conductive 
or sensorineural hearing loss; neonates that spend more 
than 48 hours in the ICU and neonatal infections16,17.
The data collected were from newborns submitted 
to neonatal hearing screening by means of capturing 
otoacoustic emissions by transient stimulus, using the Ca-
pella OAE analyzer in order to analyze cochlear function 
integrity and to rule out the likelihood of the baby having 
sensorineural hearing loss. According to GATANU, we 
considered as a pass criterion, the presence of response 
above 6 dB in at least 3 frequency bands (the frequencies 
tested were 1; 1.5; 2; 3 and 4 KHz) with response repro-
ducibility above 50%11,18.
Research results were descriptively analyzed throu-
gh the calculation of averages and proportions. We used 
the Z test for analysis of independent samples and the 
Odds Ratio in order to analyze the results obtained in 
respect of the hearing loss. The significance level used 
was of 5%.
The data collected was stored and analyzed using 
Excel 2002® (Microsoft Corporation). We calculated 
the specific frequencies of variables and mean values; 
afterwards we created binomial tables with crossovers 
among the variables studied. The simple logistics regres-
sion test was used to compare the proportions, when we 
assessed whether or not there were associations between 
two or more variables. The significance level (p value) 
was used to quantify the possibility of our figures present 
a random distribution. Values below 5% (p<0.05) were 
deemed significant. The Odds ratio was used in order to 
calculate the association strength between two variables, so 
as to quantify the possibility of a risk factor be associated 
with the event being studied, with a confidence interval 
of 95%. We also used the Z test to compare the results 
classified by age, gender and the incidence of risk factors 
associated with hearing impairment. In such a case, the 
5% (or 0.05) significance level was accepted to reject the 
null hypothesis.
RESULTS
From September of 2003 to December of 2006, 
we carried out NAS in 2002 newborns (NB) in a private 
hospital in the city of Maceió. Of these, 1,626 matched the 
inclusion criteria, 791 (48.6%) were girls and 835 (51.4%) 
were boys (Fig. 1). Among baby boys, 718 (44.2%) passed 
the NAS; 13 (0.8%) failed on the left ear; 8 (0.5%) failed 
on the right ear and 40 (2.5%) failed on both ears. Among 
baby girls, 698 (42.9%) passed; 7 (0.4%) failed on the left 
ear; 9 (0.6%) failed on the right ear and 16 (1.0%) failed 
on both ears, as one can see on Fig. 2. we did not observe 
any significant difference among the incidences associated 
with gender (p= 0.3436).
Figure 1. Percentage sample distribution by gender - no legend
Figure 2. Percentage distribution of NAS results by gender - no 
legend
In relation to the tests carried out by ear, we noticed 
that in the right ear there were 1,581 (48.62%) tests, while 
on the left ear they were 1,580 (48.59%), having that 91 
(2.80%) ears were not assessed. Figure 3 shows that on 
the right ear, 
1,488 (91.64%) passed the NAS and 73 (4.49%) fai-
led, on the left ear, 1,472 (90.59%) passed and 76 (4.67%) 
failed. When the Z test was used, p was equal to 0.2961 
indicating a non-significant difference of results in relation 
to the ears.
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The most frequent age range at which the NB un-
derwent NAS, as one can see in Figure 4, was the 16 to 
30 days interval. This data was significant, since the value 
of p was of 0.0427.
Of the 1,626 NB seen, 1,315 (80.9%) passed the test 
and 311 (19.1%) must be referred to a retest. Of these, 194 
(11.9%) came and 117 (7.2%) did not come to the retest. 
With the retesting, we observed that in total, 1,416 (87.1%) 
NB passed the neonatal auditory screening, while 93 (5.7%) 
failed (Fig. 5). Of the ones who failed, 20 (21.5%) NB did 
not have TOAE in their left ears, 17 (18.3%) did not have it 
in their right ear and 56 (60.2%) did not have TOAE in both 
ears. The highest incidence of bilateral failure in relation 
to unilateral ones corroborates previous results present in 
the literature19. As far as gender is concerned, 61 (65.6%) 
NB were males and 32 (34.4%) were females.
Our study picked up 163 (10.0%) NB with risk 
indicators for hearing impairment. Figure 6 shows that 
the most commonly found RIHI during screening were: 
hyperbilirubinemia with visible jaundice that not neces-
sarily required complete blood transfusion; followed by 
neonates who spent more than 48 hours in the neonatal 
ICU; ototoxic medication; family history of congenital he-
aring impairment; patient stay in the incubator for more 
than 7 days; mechanical ventilation for more than 5 days; 
consanguinity; birth weight below 1,500g or small for the 
gestational age; congenital infection (syphilis, toxoplasmo-
sis, rubella, cytomegalovirus, herpes and AIDS); bacterial 
meningitis and skull-facial anomalies. With a mean value 
of 1.73 risk indicator per person. 
Figure 3. Percentage distribution of NAS results by ear - no legend
Figure 4. Percentage distribution of NAS by age range - no legend
Figure 5. Percentage distribution of NAS carried out at a private hospital 
in the city of Maceió-AL. - no legend
Figure 6. Percentage distribution of risk indicators for hearing impair-
ment - no legend
Of the NB who failed NAS, 8.6% had some risk 
indicator for hearing impairment, while 91.4% did not. 
Of those who had RIHI, 42.9% used ototoxic medication 
for more than 5 days; 21.40% stayed in the incubator for 
more than 7 days; 14.30% had family history of conge-
nital hearing impairment; 7.10% had hyperbilirubinemia 
with visible jaundice - not necessarily needing total blood 
transfusion; 7.10% used mechanical ventilation for more 
than 5 days and 7.10% remained in the neonatal ICU for 
more than 48 hours. Making up a mean value of 1.75 risk 
indicator per person.
DISCUSSION
In the present investigation, NBs who had TOAE 
present were more often males and in the right ear; howe-
ver, when we applied the Z statistical test, we perceived 
that these data were not significant. This finding does not 
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match the ones in the literature we studied6,20,21, which 
stresses a higher hearing sensitivity among women and 
in their right ears, making them have a greater prevalence 
of otoacoustic emissions.
NAS performance as soon as possible helps optimize 
intervention, contributing for the child’s development. On 
Figure 4 we see that most NB underwent NAS in their first 
months of life, a result which is statistically significant and 
in agreement with those from other authors22,23. This fact 
may state that health care professionals who work with 
newborns are attentive to the causes, consequences and 
the very importance of preventing hearing loss - referring 
children with hearing loss to the proper professionals such 
as the hearing therapist and the otorhinolaryngologist in 
order to carry out proper diagnosis and/or intervention24. 
Early diagnosis in hearing alterations allows for early in-
tervention still in the most critical period and it is ideal to 
stimulate hearing and speech25.
The present study showed that 87.1% passed NAS, 
5.7% failed and 7.2% did not come for retest, despite being 
advised to. It important to stress that to “pass” the test 
means that at the time of the test, results matched TOAE 
responses, in other words, showed healthy outer hair 
cells26,11. Throughout children development, acquired hea-
ring loss stemming from: secretory otitis media, infections, 
ototoxic agents, genetic or traumatic causes can generate 
permanent hearing impairment26.
CBPAI4 states that retest indications should not go 
beyond 4%. The present investigation found an index of 
19.1%, which is significant according to the Z statistical test 
(p=0.0001), inferring a high number of NB referred for a 
new assessment. This fact can be justified by the possible 
presence of noisy breathing, suction act or noise, factors 
which impair TOAE capture27.
Of those NB who had RIHI, Figure 6 shows that 
hyperbilirubinemia was the most frequently found risk 
indicator, it is described as the most common cause of 
hearing deficiency in the newborn, which can damage the 
inner ear and the central auditory pathways28. The use of 
ototoxic drugs came in second place, as well as consan-
guinity, genetic hearing loss and the infections diseases 
that can cause hearing impairment. The same may happen 
to the NBs who stay in the ICU, for having greater frailty, 
they may be affected by diseases, procedures or drugs 
after having been discharged from the nursery.29
According to the literature, approximately 50% of 
the children diagnosed with hearing loss did not have risk 
indicators for it27,22. In the present study, we observed that 
91.4% of those who failed the test did not have risk indi-
cators, this stresses the importance of a universal hearing 
screening program, in other words, for all NB, allowing for 
equal opportunities for diagnosis and intervention30,23.
CONCLUSION
This study disclosed the statistical results obtained 
from a neonatal hearing screening program carried out in 
the city of Maceió-AL, stressing the importance of imple-
menting and maintaining such a program. Moreover, its 
publication contributes for multinational and/or regional 
programs.
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